Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia | MicrobiomeTrials← Back to trialsNCT07808905
Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2027-03-01Est. Completion: 2029-10-31
Enrollment target: 132 participants Locations- Samsung Medical Center, Seoul, South Korea
Other microbiome trials you might be interested in
SarcopeniaIntrinsic Capacity
To evaluate the effects of a 12-week multi-component nutritional formula on World Health Organization (WHO) Integrated C…
Kaohsiung City, TaiwanEst. completion Dec 15, 2026
Head CancerNeck CancerSarcopeniaHead and Neck Cancer
This study examines the acceptability, feasibility, and safety in developing a prehabilitation program for head and neck…
Sacramento, United StatesEst. completion Dec 2026